Abstract
In the previous chapter, we introduced the role of miniaturized detection systems for the detection of next-generation PCa biomarkers. Herein, we report a miniaturized, rapid, cost-efficient and minimal-equipment assay named “FusBLU” for detecting TMPRSS2-ERG gene fusions from urine.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. Ca-A Cancer J Clin 67:7–30
Polascik TJ, Oesterling JE, Partin AW (1999) Prostate specific antigen: a decade of discovery—what we have learned and where we are going. J Urol 162:293–306
Pinsky PF, Prorok PC, Kramer BS (2017) Prostate cancer screening—a perspective on the current state of the evidence. N Engl J Med 376:1285–1289
Tomlins SA et al (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310:644–648
Kumar-Sinha C, Tomlins SA, Chinnaiyan AM (2008) Recurrent gene fusions in prostate cancer. Nat Rev Cancer 8:497–511
Prensner JR, Chinnaiyan AM (2009) Oncogenic gene fusions in epithelial carcinomas. Curr Opin Genet & Dev 19:82–91
Wang JH, Cai Y, Ren CX, Ittmann M (2006) Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. Can Res 66:8347–8351
Tomlins SA et al (2011) Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. Sci Transl Med 3:94ra72
Nilsson J et al (2009) Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer 100:1603–1607
Dijkstra S, Mulders PFA, Schalken JA et al (2009) Clinical use of novel urine and blood based prostate cancer biomarkers: a review. Clin Biochem 47:889–896
Koo KM, Wee EJH, Mainwaring PN, Trau M (2016) A simple, rapid, low-cost technique for naked-eye detection of urine-isolated TMPRSS2: ERG gene fusion RNA. Sci Rep 6:30722
Koo KM, Carrascosa LG, Trau M (2018) DNA-directed assembly of copper nanoblocks with inbuilt fluorescent and electrochemical properties: application in simultaneous amplification-free analysis of multiple RNA species. Nano Res 11:940–952
Koo KM, Wee EJH, Wang Y, Trau M (2017) Enabling miniaturised personalised diagnostics: from lab-on-a-chip to lab-in-a-drop. Lab Chip 17:3200–3220
Koo KM, Carrascosa LG, Shiddiky MJA, Trau M (2016) Amplification-free detection of gene fusions in prostate cancer urinary samples Using mRNA-gold affinity interactions. Anal Chem 88:6781–6788
Gundem G et al (2015) The evolutionary history of lethal metastatic prostate cancer. Nature 520:353–357
Clark JP, Cooper CS (2009) ETS gene fusions in prostate cancer. Nat Rev Urol 6:429–439
Prensner JR, Rubin MA, Wei JT Chinnaiyan, AM (2012) Beyond PSA: the next generation of prostate cancer biomarkers. Sci Transl Med 4:127rv3 (2012)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Koo, K.M. (2019). Colorimetric Gene Fusion Diagnostics for Visual Binary Readout. In: Advancing Gene Fusion Detection Towards Personalized Cancer Nanodiagnostics . Springer Theses. Springer, Cham. https://doi.org/10.1007/978-3-030-31000-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-31000-4_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-30999-2
Online ISBN: 978-3-030-31000-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)